Bioanalytical and clinical research laboratories are tasked with providing high quality analytical results from complex biological samples in a high throughput environment while complying with strict legislation. These demands are compounded by the continued drive to higher potency drugs and long acting formulations which continue to push the required quantification limits to lower levels. The growth of biopharmaceuticals also brings into consideration additional analytical challenges such as solvation and non-specific binding.
In this presentation we will discuss how new developments in the design of micro elution SPE formats can help meet these challenges.
What will I learn?
Who should attend:
Global Product Manager for Sample Preparation
Thermo Fisher Scientific